Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer
Goldkorn, et al. J Clin Oncol. 2014 Apr 10;32(11):1136-42. doi: 10.1200/JCO.2013.51.7417. Epub 2014 Mar 10.
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
Aggarwal, et al. Ann Oncol. 2013 Feb;24(2):420-8. doi: 10.1093/annonc/mds336. Epub 2012 Oct 1.
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
Muller, et al. Breast Cancer Res. 2012 Aug 15;14(4):R118. doi: 10.1186/bcr3243.
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.
Scher, et al. Lancet Oncol. 2009 Mar;10(3):233-9. doi: 10.1016/S1470-2045(08)70340-1. Epub 2009 Feb 11.
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.
de Bono, et al. Clin Cancer Res. 2008 Oct 1;14(19):6302-9. doi: 10.1158/1078-0432.CCR-08-0872.
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Cohen, et al. J Clin Oncol. 2008 Jul 1;26(19):3213-21. doi: 10.1200/JCO.2007.15.8923.
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Danila, et al. Clin Cancer Res. 2007 Dec 1;13(23):7053-8.
Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer
Budd, et al. Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-1769 November 1, 2006 12; 6403-09.
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
Cristofanilli, et al. Journal of Clinical Oncology doi: 10.1200/JCO.2005.08.140 JCO March 1, 2005 vol. 23 no. 7 1420-1430
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
Cristofanilli, et al. The new England Journal of Medicine 2004; 351:781-791 August 19, 2004DOI: 10.1056/NEJMoa040766
Circulating tumor cells and [18F]Fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer
De Giorgi, et al. J Clin Oncol 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18.
The Safety Data Sheets for In-Vitro Diagnostics are listed below by kit and country. Multiple languages are available in some countries. Each file below contains a collection of Safety Data Sheets for all reagents within the kit.
Send any questions regarding Safety Data Sheets to